Cantor Fitzgerald L. P. bought a new position in shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 127,500 shares of the company’s stock, valued at approximately $412,000. Cantor Fitzgerald L. P. owned approximately 0.15% of Larimar Therapeutics as of its most recent SEC filing. Several other…